Kestra Medical Technologies (KMTS) insider plans 6,275-share NASDAQ stock sale

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. insider Alfred J. Ford filed notice of a planned sale of 6,275 shares of common stock through Merrill Lynch on NASDAQ on 08/04/2026, with an indicated value of $151,140.78. These shares relate to restricted stock units that vest on 07/17/2026 under the issuer’s equity compensation plan.

Over the prior three months, Alfred J. Ford reported sales of 5,936 shares for $135,120.73 on 07/30/2026, 8,681 shares for $196,284.58 on 07/31/2026, and 13,015 shares for $311,118.83 on 08/03/2026.

Key Figures

Planned shares to be sold: 6,275 shares Planned sale value: $151,140.78 Sale 1 in past 3 months: 5,936 shares for $135,120.73 +3 more

6 metrics

Planned shares to be sold 6,275 shares Common stock planned sale on NASDAQ dated 08/04/2026

Planned sale value $151,140.78 Indicated value for 6,275 shares in planned transaction

Sale 1 in past 3 months 5,936 shares for $135,120.73 Common stock sale on 07/30/2026 by Alfred J. Ford

Sale 2 in past 3 months 8,681 shares for $196,284.58 Common stock sale on 07/31/2026 by Alfred J. Ford

Sale 3 in past 3 months 13,015 shares for $311,118.83 Common stock sale on 08/03/2026 by Alfred J. Ford

RSU vesting shares 6,275 shares Vesting of restricted stock unit awards on 07/17/2026

Key Terms

Form 144, restricted stock unit awards, equity compensation plan, common stock

4 terms

Form 144 regulatory

"144: Securities To Be Sold Common Stock | Merrill Lynch"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock unit awards financial

"Vesting of restricted stock unit awards | KESTRA MEDICAL"

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

common stock financial

"Common Stock | 07/30/2026 | 5936 | 135120.73"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:33 PM Accepted by SEC EDGAR 08/04/2026 - 04:32 PM Learn about SEC filing dates

FAQ

What does Kestra Medical Technologies (KMTS) report in this Form 144?

The filing reports that Alfred J. Ford plans to sell 6,275 shares of KMTS common stock on NASDAQ on 08/04/2026, with an indicated value of $151,140.78.

How many KMTS shares is Alfred J. Ford planning to sell and through whom?

Alfred J. Ford plans to sell 6,275 shares of Kestra Medical Technologies common stock through Merrill Lynch, with the transaction listed for NASDAQ trading on 08/04/2026.

What KMTS insider sales were made in the past three months?

Alfred J. Ford reported selling 5,936 shares for $135,120.73 on 07/30/2026, 8,681 shares for $196,284.58 on 07/31/2026, and 13,015 shares for $311,118.83 on 08/03/2026.

What is the source of the KMTS shares being sold by Alfred J. Ford?

The 6,275 shares are tied to the vesting of restricted stock unit awards on 07/17/2026, granted as part of Kestra Medical Technologies’ equity compensation plan.

On which exchange will the KMTS Form 144 shares be sold?

The 6,275 KMTS common shares covered by the Form 144 are listed for sale on the NASDAQ market, with Merrill Lynch identified as the broker handling the transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	6275	151140.78	58602497	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of restricted stock unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			6275	07/17/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alfred J Ford 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/30/2026	5936	135120.73
Alfred J Ford 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/31/2026	8681	196284.58
Alfred J Ford 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	08/03/2026	13015	311118.83

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)